[go: up one dir, main page]

DE60025705D1 - Antikonvulsive derivate zur behandlung von essentiellem tremor - Google Patents

Antikonvulsive derivate zur behandlung von essentiellem tremor

Info

Publication number
DE60025705D1
DE60025705D1 DE60025705T DE60025705T DE60025705D1 DE 60025705 D1 DE60025705 D1 DE 60025705D1 DE 60025705 T DE60025705 T DE 60025705T DE 60025705 T DE60025705 T DE 60025705T DE 60025705 D1 DE60025705 D1 DE 60025705D1
Authority
DE
Germany
Prior art keywords
treatment
essential tremor
anticonvulsive
derivatives
anticonvulsive derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE60025705T
Other languages
English (en)
Other versions
DE60025705T2 (de
Inventor
S Connor
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceuticals Inc
Original Assignee
Ortho McNeil Pharmaceutical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho McNeil Pharmaceutical Inc filed Critical Ortho McNeil Pharmaceutical Inc
Application granted granted Critical
Publication of DE60025705D1 publication Critical patent/DE60025705D1/de
Publication of DE60025705T2 publication Critical patent/DE60025705T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/351—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom not condensed with another ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Psychology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Saccharide Compounds (AREA)
DE60025705T 1999-02-17 2000-02-15 Antikonvulsive derivate zur behandlung von essentiellem tremor Expired - Fee Related DE60025705T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US12041399P 1999-02-17 1999-02-17
US120413P 1999-02-17
PCT/US2000/003849 WO2000048549A2 (en) 1999-02-17 2000-02-15 Anticonvulsant derivatives useful in treating essential tremor

Publications (2)

Publication Number Publication Date
DE60025705D1 true DE60025705D1 (de) 2006-04-13
DE60025705T2 DE60025705T2 (de) 2006-08-24

Family

ID=22390119

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025705T Expired - Fee Related DE60025705T2 (de) 1999-02-17 2000-02-15 Antikonvulsive derivate zur behandlung von essentiellem tremor

Country Status (24)

Country Link
US (1) US6214867B1 (de)
EP (1) EP1158950B1 (de)
JP (1) JP2002539088A (de)
KR (1) KR100664612B1 (de)
CN (1) CN1433306A (de)
AR (1) AR035986A1 (de)
AT (1) ATE316374T1 (de)
AU (1) AU779823B2 (de)
BR (1) BR0008791A (de)
CA (1) CA2362336C (de)
CZ (1) CZ295096B6 (de)
DE (1) DE60025705T2 (de)
DK (1) DK1158950T3 (de)
ES (1) ES2257288T3 (de)
HU (1) HUP0202634A3 (de)
IL (2) IL144943A0 (de)
MX (1) MXPA01008387A (de)
MY (1) MY129238A (de)
NO (1) NO20014026L (de)
NZ (1) NZ513724A (de)
TR (1) TR200103126T2 (de)
TW (1) TWI228413B (de)
WO (1) WO2000048549A2 (de)
ZA (1) ZA200107564B (de)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002043731A2 (en) * 2000-11-30 2002-06-06 University Of Florida Treatments for neurogenetic disorders, impulse control disorders, and wound healing
MXPA04002709A (es) * 2001-09-24 2005-06-06 Johnson & Johnson Derivados articonvulsivos utiles para el tratamiento del sindrome de extremidades inquietas y trastorno periodico del movimiento de extremidades.
US8652527B1 (en) 2013-03-13 2014-02-18 Upsher-Smith Laboratories, Inc Extended-release topiramate capsules
US9101545B2 (en) 2013-03-15 2015-08-11 Upsher-Smith Laboratories, Inc. Extended-release topiramate capsules

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4513006A (en) * 1983-09-26 1985-04-23 Mcneil Lab., Inc. Anticonvulsant sulfamate derivatives
US4981867A (en) 1989-12-08 1991-01-01 The Board Of Trustees Of The Leland Stanford Junior University Treatment of tremor using compounds that depress calcium currents in thalamic and other central nervous system neurons
IL103172A (en) * 1991-09-19 1997-01-10 Mcneilab Inc Preparation of chlorosulfate and sulfamate derivatives of 2, 3:4, 5-bis-o-(1-methylethylidene)-beta-d-fructopyranose and (1-methylcyclohexyl) methanol
US5735693A (en) * 1996-03-29 1998-04-07 Multi Lingua Ltd.. Method and device for learning a foreign language
UA65607C2 (uk) 1998-03-04 2004-04-15 Орто-Макнейл Фармацевтикал, Інк. Фармацевтична композиція (варіанти) та спосіб її приготування

Also Published As

Publication number Publication date
KR20010112272A (ko) 2001-12-20
AU3364800A (en) 2000-09-04
DK1158950T3 (da) 2006-04-24
NO20014026D0 (no) 2001-08-17
MXPA01008387A (es) 2003-06-06
CA2362336A1 (en) 2000-08-24
ES2257288T3 (es) 2006-08-01
NZ513724A (en) 2004-01-30
HUP0202634A3 (en) 2005-02-28
CN1433306A (zh) 2003-07-30
CA2362336C (en) 2005-04-12
DE60025705T2 (de) 2006-08-24
AR035986A1 (es) 2004-08-04
WO2000048549A2 (en) 2000-08-24
KR100664612B1 (ko) 2007-01-04
ZA200107564B (en) 2002-12-13
IL144943A (en) 2006-08-20
JP2002539088A (ja) 2002-11-19
TWI228413B (en) 2005-03-01
AU779823B2 (en) 2005-02-10
WO2000048549A3 (en) 2002-04-04
EP1158950A1 (de) 2001-12-05
BR0008791A (pt) 2005-04-05
CZ295096B6 (cs) 2005-05-18
MY129238A (en) 2007-03-30
NO20014026L (no) 2001-10-17
CZ20013011A3 (cs) 2002-06-12
US6214867B1 (en) 2001-04-10
EP1158950B1 (de) 2006-01-25
IL144943A0 (en) 2002-06-30
ATE316374T1 (de) 2006-02-15
TR200103126T2 (tr) 2002-07-22
HUP0202634A2 (hu) 2002-11-28

Similar Documents

Publication Publication Date Title
DE60019556D1 (de) 2-amino-benzoxazinonderivate zur behandlung von fettleibigkeit
DE60019555D1 (de) 2-oxy-benzoxazinonderivate zur behandlung von fettleibigkeit
ATE275145T1 (de) Chinazolinderivate zur behandlung von tumoren
ATE308997T1 (de) Mittel zur behandlung von erkrankungen der speiseröhre
ATE308527T1 (de) Phenylamino-substituierte triicyclische derivate zur behandlung hyperproliferativer krankheiten
DE60124302D1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
ATE269303T1 (de) Arylpiperazinyl-cyclohexyl indolderivate zur behandlung von depressionen
DE60142473D1 (de) Intrakorporale medikamente zur photodynamischen behandlung von erkrankungen
ATE447947T1 (de) Pharmazeutische zubereitungen zur behandlung von insulinresitenz
ATE455106T1 (de) Acyl derivate zur behandlung von krankheiten die in zusammenhang mit vla-4 stehen
DE69925306D1 (de) Behandlung von kohlenwasserstoffgas
DE60028358D1 (de) Hmg1 antagonisten zur behandlung von entzündungen
DE60022916D1 (de) Reboxetin zur Behandlung von peripheren Neuropathien
DE10082139T1 (de) Zusammensetzung zur Behandlung von Reibungspaaren
ATE292134T1 (de) Neue oxabispidin-verbindungen zur behandlung von herzarrhythmien
DE60136477D1 (de) Retinoide zur behandlung von emphysem
DE50013843D1 (de) Arzneimittel zur behandlung von darmerkrankungen
EP1117431A4 (de) Behandlung von acidose
ATE226071T1 (de) Antikonvulsive derivate zur behandlung von neuropathischem schmerz
DE60238765D1 (de) Carbamatverbindungen zur behandlung von schmerz
DE60018200D1 (de) Verwendung von pleuromutilinderivaten zur transdermalen behandlung bakterieller erkrankungen
DE60021252D1 (de) Antikonvulsiva zur behandlung von autismus
ATE285764T1 (de) Rivastigmine zur behandlung von augenerkrankungen
ATE316374T1 (de) Antikonvulsive derivate zur behandlung von essentiellem tremor
ATE251167T1 (de) Oxazinocarbazole zur behandlung von cns- erkrankungen

Legal Events

Date Code Title Description
8328 Change in the person/name/address of the agent

Representative=s name: BOEHMERT & BOEHMERT, 28209 BREMEN

8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee